BR112015017546A2 - composições hemostáticas, usos das mesmas e kit - Google Patents

composições hemostáticas, usos das mesmas e kit

Info

Publication number
BR112015017546A2
BR112015017546A2 BR112015017546A BR112015017546A BR112015017546A2 BR 112015017546 A2 BR112015017546 A2 BR 112015017546A2 BR 112015017546 A BR112015017546 A BR 112015017546A BR 112015017546 A BR112015017546 A BR 112015017546A BR 112015017546 A2 BR112015017546 A2 BR 112015017546A2
Authority
BR
Brazil
Prior art keywords
compositions
composition
hemostatic compositions
kit
thrombin
Prior art date
Application number
BR112015017546A
Other languages
English (en)
Inventor
Murat Moreno Jesús
Rámon Rodríguez Fernández-Alba Juan
Original Assignee
Thrombotargets Europe S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombotargets Europe S L filed Critical Thrombotargets Europe S L
Publication of BR112015017546A2 publication Critical patent/BR112015017546A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

resumo patente de invenção: "composições hemostáticas". a invenção refere-se a uma composição que compreende uma combinação de fator tecidual submetido a lipídio e trombina, em que a quantidade de trombina é compreendida de 1 a 30 iu por grama de composição, e a quantidade de fator tecidual submetido a lipídio é compreendida de 5 a 150 ng por grama de composição. a presente invenção também fornece composições farmacêuticas ou veterinárias, assim como as composições hemostáticas. as composições da invenção são úteis no tratamento de hemorragias.
BR112015017546A 2013-01-24 2014-01-23 composições hemostáticas, usos das mesmas e kit BR112015017546A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13152475.3A EP2759305A1 (en) 2013-01-24 2013-01-24 Hemostatic compositions
PCT/EP2014/051340 WO2014114719A1 (en) 2013-01-24 2014-01-23 Hemostatic compositions

Publications (1)

Publication Number Publication Date
BR112015017546A2 true BR112015017546A2 (pt) 2017-11-21

Family

ID=47603437

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015017546A BR112015017546A2 (pt) 2013-01-24 2014-01-23 composições hemostáticas, usos das mesmas e kit

Country Status (9)

Country Link
US (1) US20160000863A1 (pt)
EP (2) EP2759305A1 (pt)
JP (1) JP6404833B2 (pt)
CN (1) CN104994869B (pt)
AU (1) AU2014209886B2 (pt)
BR (1) BR112015017546A2 (pt)
ES (1) ES2626806T3 (pt)
MX (1) MX2015009348A (pt)
WO (1) WO2014114719A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105296433B (zh) 2014-08-01 2018-02-09 中山康方生物医药有限公司 一种ctla4抗体、其药物组合物及其用途
WO2018035710A1 (en) 2016-08-23 2018-03-01 Akeso Biopharma, Inc. Anti-ctla4 antibodies
US11654057B2 (en) 2020-04-09 2023-05-23 Bio 54, Llc Devices for bleeding reduction and methods of making and using the same
US11642324B1 (en) 2022-03-01 2023-05-09 Bio 54, Llc Topical tranexamic acid compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029792A1 (en) * 1996-02-20 1997-08-21 Cohesion Corporation Tissue sealant compositions and methods of use thereof
AU9786198A (en) * 1997-10-10 1999-05-03 University Of Virginia Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids
EP1749536A1 (en) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Activated factor X stimulants as new antihemorrhagic agents for topical use
EP1939218A1 (en) * 2006-12-29 2008-07-02 Thrombotargets Europe, S.L. Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
EP2145695A1 (de) 2008-07-14 2010-01-20 Sika Technology AG Vorrichtung zur Klebstoffapplikation
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
EP2380905A1 (en) 2010-04-19 2011-10-26 Thrombotargets Europe, S.L. Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof

Also Published As

Publication number Publication date
MX2015009348A (es) 2016-06-21
AU2014209886B2 (en) 2018-11-29
CN104994869A (zh) 2015-10-21
US20160000863A1 (en) 2016-01-07
EP2759305A1 (en) 2014-07-30
CN104994869B (zh) 2020-07-07
WO2014114719A1 (en) 2014-07-31
ES2626806T3 (es) 2017-07-26
EP2948169A1 (en) 2015-12-02
JP6404833B2 (ja) 2018-10-17
JP2016506920A (ja) 2016-03-07
AU2014209886A1 (en) 2015-08-06
EP2948169B1 (en) 2017-03-22

Similar Documents

Publication Publication Date Title
BR112017018368A2 (pt) composições contendo rna para o tratamento de doenças tumorais
BR112014026703A2 (pt) inibidores de dna-pk
BR112017012327A2 (pt) benzamidas substituídas por 1,3-tiazol-2-il.
PH12015500800A1 (en) Substituted benzene compounds
BR112014019431A8 (pt) Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
MX2017009767A (es) Nuevas proteínas específicas para la angiogénesis.
BR112015029611A2 (pt) composições para uso em ruptura de cartilagem
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
BR112012016633A2 (pt) composição farmacêutica em pó seco e método de tratamento de ferida.
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
BR112015018838A2 (pt) estabilidade melhorada de novas composições líquidas
BR112014024672A8 (pt) Composições farmacêuticas para terapia de combinação
BR112015024846A2 (pt) composições para utilização no estímulo do crescimento ósseo
BR112014003109A2 (pt) variantes de plasminogênio e plasmina
BR112015001313A2 (pt) composições de vacina
BR112014003071A2 (pt) tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical
BR112012019921A2 (pt) composições líquidas compreendendo um agente de resfriamento não-metol e um espessante para tratamento de um sintoma respiratório.
BR112015017546A2 (pt) composições hemostáticas, usos das mesmas e kit
BR112015013125A2 (pt) tratamento de lesões orais usando composições de matrix placentário extracelular
MX2011009277A (es) Composicion de leucocito activada.
BR112013032911A2 (pt) leucotoxina e/d como um novo agente anti-inflamatório e microbicida
BR112015014367A2 (pt) formulações inibidoras de lfa-1
BR112014027213A2 (pt) nova composição de alfentanil para o tratamento da dor aguda
BR112013033438A2 (pt) dha e epa na redução do estresse oxidativo
BR112015023368A2 (pt) método de tratamento de deficiência de vitamina b12

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.